| For: | Choi HJ, Kim DG, Na GH, Han JH, Hong TH, You YK. Clinical outcome in patients with hepatocellular carcinoma after living-donor liver transplantation. World J Gastroenterol 2013; 19(29): 4737-4744 [PMID: 23922471 DOI: 10.3748/wjg.v19.i29.4737] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v19/i29/4737.htm |
| Number | Citing Articles |
| 1 |
Qing Pang, Kai Qu, Jing-Yao Zhang, Si-Dong Song, Su-Shun Liu, Ming-Hui Tai, Hao-Chen Liu, Chang Liu. The Prognostic Value of Platelet Count in Patients With Hepatocellular Carcinoma. Medicine 2015; 94(37) doi: 10.1097/MD.0000000000001431
|
| 2 |
2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma. Journal of Liver Cancer 2023; 23(1) doi: 10.17998/jlc.2022.11.07
|
| 3 |
Jiliang Feng, Ruidong Zhu, Dezhao Feng, Lu Yu, Dawei Zhao, Jushan Wu, Chunwang Yuan, Junmei Chen, Yan Zhang, Xiu Zheng. Prediction of Early Recurrence of Solitary Hepatocellular Carcinoma after Orthotopic Liver Transplantation. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-52427-8
|
| 4 |
Emanuel Eguia, Talia Baker, Marshall Baker. Gastrointestinal Malignancies. Cancer Treatment and Research 2024; 192 doi: 10.1007/978-3-031-61238-1_10
|
| 5 |
Stefano Di Sandro, Leonardo Centonze, Barbara Catellani, Roberta Odorizzi, Daniela Caracciolo, Cristiano Guidetti, Paolo Magistri, Giuseppe Esposito, Gian Piero Guerrini, Fabrizio Di Benedetto. Current role and perspectives of living donor liver transplantation for hepatocellular carcinoma: systematic review of the past 20 years. Updates in Surgery 2025; 77(6) doi: 10.1007/s13304-024-01862-y
|
| 6 |
S. V. Gautier, A. R. Monakhov, O. M. Tsirulnikova, S. I. Zubenko, E. V. Sitnikova, D. V. Umrik, K. A. Nosov, N. D. Kurtak. Outcomes of liver transplantation in hepatocellular carcinoma: a single-center experience. Annaly khirurgicheskoy gepatologii = Annals of HPB Surgery 2020; 25(2) doi: 10.16931/1995-5464.2020267-76
|
| 7 |
Yuntao Bing, Maolin Tian, Gang Li, Bin Jiang, Zhaolai Ma, Lei Li, Liang Wang, Hangyan Wang, Dianrong Xiu. Down-regulated of PCDH10 predicts poor prognosis in hepatocellular carcinoma patients. Medicine 2018; 97(35) doi: 10.1097/MD.0000000000012055
|
| 8 |
Luciana dos Santos Schraiber, Angelo Alves de Mattos, Maria Lucia Zanotelli, Guido Pio Cracco Cantisani, Ajácio Bandeira de Mello Brandão, Cludio Augusto Marroni, Guilhermo Kiss, Lucas Ernani, Patrícia dos Santos Marcon. Alpha-fetoprotein Level Predicts Recurrence After Transplantation in Hepatocellular Carcinoma. Medicine 2016; 95(3) doi: 10.1097/MD.0000000000002478
|
| 9 |
Diana Rodríguez-Espinosa, Laura Morantes, Jenmy García, José Jesús Broseta, Elena Cuadrado-Payán, Jordi Colmenero, Josep Vicens Torregrosa, Fritz Diekmann, Nuria Esforzado. Long-Term Outcomes of Incidental Liver Malignancies in Simultaneous Liver-Kidney Transplant Recipients. Transplantation Proceedings 2024; 56(2) doi: 10.1016/j.transproceed.2024.01.004
|
| 10 |
Dami Ko, Insook Lee, Rebecca J Muehrer. Informational needs of liver transplant recipients during a two-year posttransplant period. Chronic Illness 2016; 12(1) doi: 10.1177/1742395315601415
|
| 11 |
Jan Lerut, Maxime Foguenne, Quirino Lai. Hepatocellular cancer selection systems and liver transplantation: from the tower of babel to an ideal comprehensive score. Updates in Surgery 2021; 73(5) doi: 10.1007/s13304-021-01078-4
|
| 12 |
Hsin-Rou Liang, Chia-En Hsieh, Kuo-Hua Lin, Chih-Jan Ko, Yu-Ju Hung, Ya-Lan Hsu, Yao-Li Chen. Living donor liver transplantation for hepatocellular carcinoma beyond the Milan criteria: outcome of expanded criteria in tumor size. BMC Surgery 2021; 21(1) doi: 10.1186/s12893-021-01403-z
|
| 13 |
Lauren E. Matevish, Andrew D. Shubin, Ahmad Anouti, Jai Prasadh, Parsia A. Vagefi, Madhukar S. Patel. Living Donor Liver Transplantation in North America: Current Status and Expanding Indications. Current Surgery Reports 2025; 13(1) doi: 10.1007/s40137-025-00457-9
|
| 14 |
2018 Korean Liver Cancer Association–National Cancer Center Korea Practice Guidelines for the Management of Hepatocellular Carcinoma. Korean Journal of Radiology 2019; 20(7) doi: 10.3348/kjr.2019.0140
|
| 15 |
Olga Kantor, Marshall S. Baker. Gastrointestinal Malignancies. Cancer Treatment and Research 2016; doi: 10.1007/978-3-319-34244-3_8
|
| 16 |
Hwi Young Jang, Joon-Il Choi, Young Joon Lee, Michael Yong Park, Dong Myung Yeo, Sung Eun Rha, Eun Sun Jung, Young Kyoung You, Dong Goo Kim, Jae Young Byun. Performance of Gadoxetic Acid–Enhanced Liver Magnetic Resonance Imaging for Predicting Patient Eligibility for Liver Transplantation Based on the Milan Criteria. Journal of Computer Assisted Tomography 2017; 41(1) doi: 10.1097/RCT.0000000000000476
|
| 17 |
Venkat Sumanth Potluri, Julio Sokolich, Jacentha Buggs, William Mcclellan, Ebonie Rogers, Kristina Barber, Kristal Cocuy, Ambuj Kumar, Victor Bowers. Outcomes in Hepatocellular Carcinoma Liver Transplantation before and after the Mandated Six-Month Wait Time. The American Surgeon™ 2019; 85(8) doi: 10.1177/000313481908500845
|
| 18 |
KLCA Korean Liver Cancer Association, NCC National Cancer Center. 2018 Korean Liver Cancer Association–National Cancer Center Korea Practice Guidelines for the Management of Hepatocellular Carcinoma. Gut and Liver 2019; 13(3) doi: 10.5009/gnl19024
|
| 19 |
2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma. Clinical and Molecular Hepatology 2022; 28(4) doi: 10.3350/cmh.2022.0294
|
| 20 |
Beili Wang, Feng Li, Luya Cheng, Yanxia Zhan, Boting Wu, Pu Chen, Junfei Shen, Wenhao Wu, Xiaolu Ma, Jie Zhu, Baishen Pan, Wei Guo, Yunfeng Cheng. The Pretreatment Platelet Count is an Independent Predictor of Tumor Progression in Patients Undergoing Transcatheter Arterial Chemoembolization with Hepatitis B Virus-Related Hepatocellular Carcinoma. Future Oncology 2019; 15(8) doi: 10.2217/fon-2018-0591
|
| 21 |
Jae Hyun Yoon, Sung Kyu Choi. Management of early-stage hepatocellular carcinoma: challenges and strategies for optimal outcomes. Journal of Liver Cancer 2023; 23(2) doi: 10.17998/jlc.2023.08.27
|
| 22 |
2014 Korean Liver Cancer Study Group-National Cancer Center Korea Practice Guideline for the Management of Hepatocellular Carcinoma. Korean Journal of Radiology 2015; 16(3) doi: 10.3348/kjr.2015.16.3.465
|
| 23 |
2022 KLCA-NCC Korea Practice Guidelines for the Management of Hepatocellular Carcinoma. Korean Journal of Radiology 2022; 23(12) doi: 10.3348/kjr.2022.0822
|
| 24 |
Arndt Vogel, Martina Sterneck, Florian Vondran, Oliver Waidmann, Ingo Klein, Udo Lindig, Silvio Nadalin, Utz Settmacher, Frank Tacke, Hans Jürgen Schlitt, Henning Wege. Der Einsatz der immunonkologischen Therapie beim hepatozellulären Karzinom im Kontext der Lebertransplantation
Eine interdisziplinäre Risiko-Nutzen-Abwägung
. Zeitschrift für Gastroenterologie 2022; 60(02) doi: 10.1055/a-1649-8643
|
| 25 |
Dongsub Jeon, Gi‐Won Song, Han Chu Lee, Ju Hyun Shim. Treatment patterns for hepatocellular carcinoma in patients with Child–Pugh class B and their impact on survival: A Korean nationwide registry study. Liver International 2022; 42(12) doi: 10.1111/liv.15464
|